Jinwang Ding

Jinwang Ding

Auto-generated profile, based on publicly available information

Jinwang Ding

Department of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YZYi Zhang
Yi Zhang
LLLian Liu
Lian Liu
QQQiongzi Qiu
Qiongzi Qiu
QZQing Zhou
Qing Zhou
JDJinwang Ding
Jinwang Ding
PLPengyuan Liu
Pengyuan Liu
Occurring in over 60% of human genes, alternative polyadenylation (APA) results in numerous transcripts with differing 3’ends, thus greatly expanding the diversity of mRNAs and of proteins derived from a single gene. As a key molecular mechanism, APA is involved in various gene regulation steps including mRNA maturation, mRNA stability, cellular RNA decay, and protein diversification. APA is frequently dysregulated in cancers leading to changes in oncogenes and tumor suppressor gene expressions. Recent studies have revealed various APA regulatory mechanisms that promote the development and progression of a number of human diseases, including cancer. Here, we provide an overview of four types of APA and their impacts on gene regulation. We focus particularly on the interaction of APA with microRNAs, RNA binding proteins and other related factors, the core pre-mRNA 3’end processing complex, and 3’UTR length change. We also describe next-generation sequencing methods and computational tools for use in poly(A) signal detection and APA repositories and databases. Finally, we summarize the current understanding of APA in cancer and provide our vision for future APA related research.

5 August 2014 in Molecules
Verified
Journal Article
Open access
PDF file
YPYou Peng
You Peng
CLChen Li
Chen Li
DLDing-Cun Luo
Ding-Cun Luo
JDJin-Wang Ding
Jin-Wang Ding
WZWo Zhang
Wo Zhang
GPGang Pan
Gang Pan
This study screened microRNAs (miRNAs) that are abnormally expressed in papillary thyroid carcinoma (PTC) tissues to identify PTC and nodular goiter and the degree of PTC malignancy. A total of 51 thyroid tumor tissue specimens paired with adjacent normal thyroid tissues were obtained from the Department of Surgical Oncology of Hangzhou First People’s Hospital from June-December 2011. miRNA expression profiles were examined by microarrays and validated by quantitative real-time PCR (qRT-PCR). Expression levels of the miRNAs were analyzed to assess if they were associated with selected clinicopathological features. Eleven miRNAs were significantly differentially expressed between nodular goiter and PTC and between highly invasive and low invasive PTC. miR-199b-5p and miR-30a-3p were significantly differentially expressed among the three groups. miR-30a-3p, miR-122-5p, miR-136-5p, miR-146b-5p and miR-199b-5p were selected for further study by qRT-PCR and miR-146b-5p, miR-199b-5p and miR-30a-3p were different between the PTC and nodular goiter groups. miR-199b-5p was over-expressed in PTC patients with extrathyroidal invasion and cervical lymph node metastasis. In conclusion miR-146b-5p, miR-30a-3p, and miR-199b-5p may serve as biomarkers for the diagnosis of PTC and miR-199b-5p is associated with PTC invasiveness.

1 September 2024 in Gland Surgery
Verified
Journal Article
Open access
PDF file
ZNZhongkai Ni
Zhongkai Ni
TZTianhan Zhou
Tianhan Zhou
HFHao Fang
Hao Fang
XLXiangfeng Lin
Xiangfeng Lin
ZXZhiyu Xing
Zhiyu Xing
HHHai Huang
Hai Huang
Background: Thyroid cancer is prone to early lymph node metastasis (LNM), and patients with large volume LNM (LVLNM) tend to have a poorer prognosis. The aim of this study was to predict LVLNM in before surgery based on radiomics and deep learning (DL). Methods: A multicenter retrospective study was performed, including 854 papillary thyroid carcinoma (PTC) patients from three centers. Radiomics features were extracted. Logistic regression (LR), support vector machine (SVM), K-nearest neighbors (KNN), multi-layer perceptron (MLP), random forest (RF), ExtraTrees, extreme gradient boosting (XGBoost), and light gradient boosting machine (LightGBM) algorithms were used to construct radiomics models. AlexNet, DenseNet121, inception_v3, ResNet50, and transformer algorithms were used to construct DL models. The receiver operating characteristic (ROC) curve was employed to select the better-performing model. A combined model was then created by merging radiomics features and DL features. The least absolute shrinkage and selection operator (LASSO) method was utilized to identify metabolites and radiomics features with non-zero coefficients. The performance of the models was evaluated using area under the curve (AUC), accuracy (ACC), sensitivity (SEN), specificity (SPE), positive predictive value (PPV), negative predictive value (NPV), and F1-score. Results: A total of 1,357 radiomics features were extracted. Among the radiomics models, the ExtraTrees model demonstrated the optimal diagnostic capabilities with an AUC of 0.787 [95% confidence interval (CI): 0.715–0.858], and DenseNet121 DL model demonstrated the optimal diagnostic capabilities with an AUC of 0.766 (95% CI: 0.683–0.848). Furthermore, the combined model, named the Thy-DL-Radiomics model, exhibited an AUC of 0.839 (95% CI: 0.758–0.920) in the internal validation set and 0.789 (95% CI: 0.718–0.859) in the external validation set. Conclusions: A radiomics-DL features integrated model can predict LVLNM in PTC patients and provide guidance for personalized treatment.

2 April 2025 in Journal of International Medical Research
Verified
Journal Article
Open access
YGYingzheng Gao
Yingzheng Gao
JDJinwang Ding
Jinwang Ding
JXJingjing Xu
Jingjing Xu
JCJiahao Chen
Jiahao Chen
WDWeidong Du
Weidong Du
Cribriform morular thyroid carcinoma is a rare thyroid malignancy with uncertain histogenesis. It predominantly affects young women and is strongly associated with familial adenomatous polyposis. This paper reports a rare case of sporadic cribriform morular thyroid carcinoma in a female patient in her early 50s, with somatic genetic testing revealing a KMT2C mutation. She presented with a solitary lesion confined to the right thyroid lobe and had no family history of familial adenomatous polyposis. Colonoscopy and germline genetic testing revealed no abnormalities. This finding suggests a potential link between KMT2C mutations and sporadic cribriform morular thyroid carcinoma. The clinical and imaging manifestations of this malignancy lack specificity, and the final diagnosis depends on routine pathological examination and immunohistochemical analysis. This report indicates the need for the clinical investigation of family history and genetic testing, thus contributing to the clinical realization of standardized follow-up monitoring and management.

1 May 2026 in Medicine
Verified
Journal Article
Open access
XQXiaogang Mmed Qi
Xiaogang Mmed Qi
ZNZhongkai Mmed Ni
Zhongkai Mmed Ni
LHLihua Mmed Hong
Lihua Mmed Hong
JDJinwang Mmed Ding
Jinwang Mmed Ding
TZTianhan Zhou
Tianhan Zhou
This study examines the clinicopathological characteristics of patients with coexistent medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC). A retrospective analysis was conducted on 169 patients who underwent surgical treatment for MTC at 2 medical centers between 2010 and 2019. The clinicopathological characteristics were documented, and associations between MTC/PTC and MTC were evaluated. Among the 169 MTC patients, 16 (9.5%) exhibited concomitant histological characteristics of both MTC and PTC. Three patterns of carcinoma distribution were identified: mixed carcinoma, tumors confined to the ipsilateral glandular lobe, and MTC/PTC lesions dispersed across both glandular lobes. Of these 16 patients, 9 were female and 7 were male, with a mean age of 50.6 years. The PTC lesions had a maximum diameter of 0.40 ± 0.21 cm, whereas the MTC lesions measured 1.73 ± 1.86 cm in maximum diameter. Additionally, 9 cases exhibited lymph node metastases, but no distant metastases were observed. Univariate analysis indicated no significant associations between MTC/PTC and MTC ( P > .05), with no differences in survival or prognosis between the groups.

12 September 2026 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
TZTianhan Zhou
Tianhan Zhou
YZYang Zhou
Yang Zhou
ZNZhongkai Ni
Zhongkai Ni
HFHao Fang
Hao Fang
FWFan Wu
Fan Wu
HHHai Huang
Hai Huang
Accurate preoperative assessment of central lymph node metastasis (CLNM) in papillary thyroid carcinoma (PTC) remains challenging. This retrospective study was registered at ClinicalTrials.gov (NCT06725628) on December 9, 2024. A total of 934 patients with confirmed PTC who underwent cervical central lymph node dissection between January 2023 and December 2024 were included. Radiomics features were extracted and selected. Deep learning models were trained and used for automatic segmentation and classification. We developed and validated a Thy-CLNM Fusion model, which achieved an AUC of 0.862, with a sensitivity of 78.9% and a specificity of 79.3% in the validation cohort. We compared the proposed model with other models that also predict CLNM, and the results demonstrated competitive performance compared with previously reported models. Histopathological slides from 231 patients were retrospectively reviewed to provide pathological interpretability. In the CLNM low-risk group, model activation predominantly localized to hyperechoic Habitat I regions, corresponding pathologically to fibrous hyperplasia and active lymphocyte–tumor cell interactions. In the CLNM high-risk group, model attention showed dominant localization in hypoechoic Habitat II regions, which were associated with nuclear atypia, poor differentiation, reduced intercellular adhesion, and vascular invasion. The proposed model offers an additional preoperative decision-support option for CLNM risk assessment in PTC patients who are planning to undergo surgery and are being considered for central lymph node dissection.